01/04/2026
American scientists invented injectable oxygen keeping people alive without breathing. This life-saving foam delivers oxygen directly into the bloodstream, buying critical minutes during respiratory emergencies. Drowning and suffocation deaths could become preventable.
The microparticle suspension developed at Boston Children's Hospital consists of millions of tiny gas-filled bubbles suspended in liquid. Each bubble contains pure oxygen wrapped in a lipid shell similar to cell membranes. When injected intravenously, these particles circulate through blood vessels, releasing oxygen directly to tissues through simple diffusion—no lungs required. The foam can sustain a person for 15-30 minutes without a single breath, providing enough time for medical intervention during asthma attacks, drowning, airway obstructions, or battlefield injuries.
Paramedics could inject cardiac arrest victims immediately, preventing brain damage from oxygen deprivation. Divers could carry emergency doses in case of equipment failure. Soldiers hit with chemical weapons that paralyze breathing muscles could survive until reaching medical facilities. Parents might keep doses in medicine cabinets for childhood choking emergencies. The applications extend to surgery, allowing certain procedures without ventilators or anesthesia breathing tubes.
The foam is stable at room temperature for months, requires no refrigeration, and administration takes seconds—just like an EpiPen. Clinical trials are showing remarkable success rates, with FDA approval expected within two years. Cost per dose should remain under $100, making it accessible for widespread emergency use. This invention could save thousands of lives annually and fundamentally change emergency medicine protocols worldwide. Science Translational Medicine, 2025